Kuwait Cancer Control Center

Quick facts

Phase 3 pipeline

• Gemcitabin/cisplatin · Oncology
  Gemcitabine and cisplatin work together as a chemotherapy combination, with gemcitabine inhibiting ribonucleotide reductase to disrupt DNA synthesis and cisplatin forming DNA crosslinks to prevent replication.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Kuwait Cancer Control Center portfolio CI brief
• Kuwait Cancer Control Center pipeline updates RSS